Zev Wainberg Selected Research

Zev Wainberg Research Topics

Disease

13	Neoplasms (Cancer) 12/2023 - 09/2010
7	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 01/2006
7	Adenocarcinoma 01/2023 - 05/2017
5	Colonic Neoplasms (Colon Cancer) 09/2015 - 11/2006
3	Pancreatic Neoplasms (Pancreatic Cancer) 02/2024 - 05/2017
2	Stomach Neoplasms (Stomach Cancer) 12/2021 - 06/2019
2	Neoplasm Metastasis (Metastasis) 11/2021 - 05/2017
1	Esophageal Squamous Cell Carcinoma 01/2023
1	Thrombocytopenia (Thrombopenia) 01/2022
1	Anemia 01/2022
1	Diarrhea 01/2022
1	Nausea 01/2022
1	Neutropenia 01/2022
1	Vomiting 01/2022
1	Fibrosis (Cirrhosis) 12/2021
1	Cardiogenic Shock 10/2021
1	Myocarditis (Carditis) 10/2021
1	Cardiomyopathies (Cardiomyopathy) 10/2021
1	Disease Progression 01/2021

Drug/Important Bio-Agent (IBA)

3	Immune Checkpoint InhibitorsIBA 01/2023 - 10/2021
3	NivolumabIBA 01/2023 - 10/2021
3	ErbB Receptors (EGF Receptor)IBA 01/2022 - 11/2006
3	Panitumumab (Vectibix)FDA Link 01/2019 - 01/2006
2	atezolizumabIBA 12/2023 - 11/2023
2	trastuzumab deruxtecanIBA 01/2023 - 01/2021
2	Irinotecan (Camptosar)FDA LinkGeneric 01/2022 - 05/2017
2	Monoclonal AntibodiesIBA 06/2019 - 01/2019
1	poliovirus receptorIBA 11/2023
1	LigandsIBA 11/2023
1	Gemcitabine FDA Link 01/2023
1	IpilimumabIBA 01/2023
1	pembrolizumabIBA 01/2023
1	B7-H1 AntigenIBA 01/2023
1	human ERBB2 proteinIBA 01/2023
1	durvalumabIBA 06/2022
1	Fluorouracil (Carac)FDA LinkGeneric 01/2022
1	pegfilgrastim (Neulasta)FDA Link 01/2022
1	folfirinoxIBA 01/2022
1	andecaliximabIBA 12/2021
1	Biomarkers (Surrogate Marker)IBA 12/2021
1	Extracellular Matrix ProteinsIBA 12/2021
1	Transforming Growth Factors (Transforming Growth Factor)IBA 12/2021
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 12/2021
1	Yttrium-90IBA 11/2021
1	Transcription Factors (Transcription Factor)IBA 02/2021
1	Topoisomerase I InhibitorsIBA 01/2021
1	Immunoconjugates (Immunoconjugate)IBA 01/2021
1	bemarituzumabIBA 06/2019
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 06/2019
1	Type 2 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 2)IBA 06/2019
1	Cetuximab (Erbitux)FDA Link 01/2019
1	Immunoglobulins (Immunoglobulin)IBA 01/2019
1	Silicon Dioxide (Silica)FDA LinkGeneric 05/2017
1	Peptides (Polypeptides)IBA 05/2017
1	Paclitaxel (Taxol)FDA LinkGeneric 05/2017
1	Lipid Bilayers (Lipid Bilayer)IBA 05/2017
1	Neuropilin-1IBA 05/2017
1	Hematoxylin (Haematoxylon)IBA 09/2015
1	Eosine Yellowish-(YS) (Eosin)IBA 09/2015
1	Keratins (Keratin)IBA 09/2015
1	Complement System Proteins (Complement)IBA 06/2015
1	Small Interfering RNA (siRNA)IBA 10/2013
1	Bevacizumab (Avastin)FDA Link 01/2006

Therapy/Procedure

10	Therapeutics 02/2024 - 09/2010
6	Drug Therapy (Chemotherapy) 01/2023 - 01/2006
4	Immunotherapy 11/2023 - 01/2019
1	Neoadjuvant Therapy 02/2024
1	Intravenous Infusions 12/2023
1	Precision Medicine 01/2023
1	Adjuvant Chemotherapy 09/2015